Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
NCT ID: NCT05175521
Last Updated: 2025-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
50 participants
INTERVENTIONAL
2021-11-11
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department
NCT02760069
Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department
NCT04464915
Inhalation Intervention for Nausea in the Emergency Department
NCT02092441
EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron
NCT02618343
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT05319860
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eucalyptus Oil Scent
Eucalyptus oil diluted in mineral oil 1:20
Eucalyptus Oil Scent
Eucalyptus oil in mineral (1:20) will be inhaled at least 30 minutes after onset of nausea associated with a migraine attack
Isopropyl Alcohol Vapors
Isopropyl Alcohol 70%
Isopropyl Alcohol Vapors
Isopropyl Alcohol 70% will be inhaled at least 30 minutes after onset of nausea associated with a migraine attack
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eucalyptus Oil Scent
Eucalyptus oil in mineral (1:20) will be inhaled at least 30 minutes after onset of nausea associated with a migraine attack
Isopropyl Alcohol Vapors
Isopropyl Alcohol 70% will be inhaled at least 30 minutes after onset of nausea associated with a migraine attack
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients without a diagnosis of acute migraine
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HonorHealth Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jill Rau, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
HonorHealth Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HonorHealth Bob Bové Neuroscience Institute
Scottsdale, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1718502
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.